2,780
Views
11
CrossRef citations to date
0
Altmetric
Articles

Radiofrequency ablation for treatment of thyroid follicular neoplasm with low SUV in PET/CT study

, , , , ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 963-969 | Received 27 Oct 2020, Accepted 27 Mar 2021, Published online: 21 Jun 2021

References

  • Baloch ZW, Fleisher S, LiVolsi VA, et al. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26(1):41–44.
  • Ahmadi S, Stang M, Jiang X, et al. Hürthle cell carcinoma: current perspectives. OncoTargets Ther. 2016;9:6873–6884.
  • Gulcelik NE, Gulcelik MA, Kuru B. Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg. 2008;134(12):1312–1315.
  • Cibas ES, Ali SZ. The 2017 Bethesda System for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–1346.
  • Shawky M, Sakr M. Hurthle cell lesion: controversies, challenges, and debates. Indian J Surg. 2016;78(1):41–48.
  • Ha SM, Sung JY, Baek JH, et al. Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes. Int J Hyperthermia. 2017;33(8):1–937.
  • Chung SR, Baek JH, Choi YJ, et al. The role of core needle biopsy for the evaluation of thyroid nodules with suspicious ultrasound features. Korean J Radiol. 2019;20(1):158–165.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
  • Yoon JH, Kwak JY, Moon HJ, et al. Ultrasonography-guided core needle biopsy did not reduce diagnostic lobectomy for thyroid nodules diagnosed as atypia of undetermined significance/follicular lesion of undetermined significance. Ultrasound Q. 2019;35(3):253–258.
  • Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–342.
  • Kim J-h, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–918.
  • Cesareo R, Pacella CM, Pasqualini V, et al. Laser ablation versus radiofrequency ablation for benign non-functioning thyroid nodules: six-month results of a randomized, parallel, open-label Trial (Lara Trial). Thyroid. 2020;30(6):847–856.
  • Lin W-C, Kan N-N, Chen H-L, et al. Efficacy and safety of single-session radiofrequency ablation for benign thyroid nodules of different sizes: a retrospective study. Int J Hyperthermia. 2020;37(1):1082–1089.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–1030.
  • Mauri G, Gennaro N, Lee MK, et al. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperthermia. 2019;36(2):13–20.
  • Mauri G, Nicosia L, Della Vigna P, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38(1):25–36.
  • Xiao J, Zhang Y, Lan Y, et al. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: a comparative study. Clin Endocrinol. 2021;94(4):684–691.
  • Kim J-H, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19(4):632–655.
  • Castellana M, Trimboli P, Piccardo A, et al. Performance of 18F-FDG PET/CT in selecting thyroid nodules with indeterminate fine-needle aspiration cytology for surgery. A systematic review and a meta-analysis. J Clin Med. 2019;8(9):1333.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
  • Bernardi S, Giudici F, Cesareo R, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian Minimally Invasive Treatments of the Thyroid Group. Thyroid. 2020;30(12):1759–1770.
  • Merten MM, Castro MR, Zhang J, et al. Examining the role of preoperative positron emission tomography/computerized tomography in combination with ultrasonography in discriminating benign from malignant cytologically indeterminate thyroid nodules. Thyroid. 2017;27(1):95–102.
  • Pathak KA, Goertzen AL, Nason RW, et al. A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms. Ann Med Surg. 2016;12:27–31.
  • Piccardo A, Puntoni M, Treglia G, et al. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. Eur J Endocrinol. 2016;174(5):693–703.
  • Rager O, Radojewski P, Dumont RA, et al. Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules. Gland Surg. 2019;8(2):S118–S125.
  • Vriens D, Adang EMM, Netea-Maier RT, et al. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. J Clin Endocrinol Metab. 2014;99(9):3263–3274.
  • Antunes CM, Taveira-Gomes A. Lobectomy in follicular thyroid neoplasms’ treatment. Int J Surg. 2013;11(9):919–922.
  • Soni N, Gedam B, Akhtar M. Thyroidectomy: post-operative complications and management. Int Surg J. 2019;6(5):1659.
  • Mihai R, Parker AJC, Roskell D, et al. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid. 2009;19(1):33–37.
  • Trimboli P, Treglia G, Guidobaldi L, et al. Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis. Endocrine. 2014;46(1):52–59.
  • Lee KH, Shin JH, Ko ES, et al. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules. Int J Surg. 2013;11(9):898–902.
  • Kuo T-C, Wu M-H, Chen K-Y, et al. Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma. Asian J Surg. 2020;43(1):339–346.
  • Paramo J, Mesko T. Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocrine Pract. 2008;14(4):447–451.
  • Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731.
  • Dobrinja C, Bernardi S, Fabris B, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol. 2015. 2015;2015:576576.
  • Zoric G, Paunovic I, Diklić A, et al. Analysis of malignancy predictors for follicular thyroid tumors. Vojnosanitetski Pregled. 2018;77:79.
  • Munoz Perez N, Villar del Moral JM, Muros Fuentes MA, et al. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm? Langenbecks Arch Surg. 2013;398(5):709–716.